Manage hypokalemia in PA patients during pregnancy or preconception
STEP 1 — Gather Information
Confirm pregnancy status, confirm PA diagnosis (or high suspicion), obtain serum potassium, assess symptoms (muscle weakness, palpitations, fatigue), review current medications (especially MRAs, diuretics, ACEi/ARB), check renal function and baseline ECG. End with: If PA suspected/confirmed and pregnant, proceed to evaluate potassium.
STEP 2 — Rule In / Rule Out
Is serum potassium <3.5 mEq/L? If yes, rule in hypokalemia and proceed to classification; if no, rule out hypokalemia and no potassium supplementation is needed.
STEP 3 — Classify or Stratify
Classify hypokalemia severity: mild (3.0–3.4 mEq/L), moderate (2.5–2.9 mEq/L), severe (<2.5 mEq/L). End with: Determine severity to guide potassium replacement dose.
STEP 4 — Decide
Initiate oral potassium supplementation (e.g., potassium chloride 20–40 mEq daily in divided doses) adjusted to severity, with goal to maintain K+ >3.5 mEq/L, and monitor serum potassium and renal function weekly.
Clinical Guardrails / Mimics / Pitfalls
Do not use MRAs (spironolactone, eplerenone, esaxerenone) for hypokalemia treatment in pregnancy due to teratogenic risk; avoid potassium-sparing diuretics; monitor for hyperkalemia, especially if renal impairment; do not exceed 100 mEq/day without close supervision; replete magnesium if deficient as it worsens refractory hypokalemia.
Concrete Clinical Example
A 32‑year‑old woman at 16 weeks gestation with known PA presents for routine visit; serum potassium is 3.2 mEq/L, she reports mild fatigue. After confirming PA and pregnancy, hypokalemia is classified as mild. She is started on potassium chloride 20 mEq orally twice daily. One week later, potassium rises to 3.8 mEq/L and symptoms improve.
Source: Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021, Japan Endocrine Society, 2021.